Table I.
Groups | EI (%) | NO (μmol/gHB) | eNOS (U/mg HB) |
---|---|---|---|
C | 21.01±1.48 | 4.136±0.322 | 21.096±2.532 |
DL | 23.58±1.99a | 5.036±0.835a | 23.893±2.393a |
DM | 25.92±1.67a,b | 5.442±0.847a,b | 25.911±2.442a,b |
DH | 23.26±1.74a | 5.139±0.969a | 24.922±4.077a |
Y | 22.02±2.47 | 4.137±0.679 | 22.264±2.631 |
YD | 24.02±1.61a | 4.648±0.715a | 23.636±1.861a |
P<0.05 compared with group C;
P<0.05 compared with group YD.
Group C, control; group DL, low concentration of dexmedetomidine; group DM, medium concentration of dexmedetomidine; group DH, high concentration of dexmedotomidine; group Y, yohimbine; group YD, yohimbine and medium concentration of dexmedetomidine. EI, erythrocyte deformability index; NO, nitic oxide; eNOS, endothelial nitric oxide synthase.